Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
22 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/accent-therapeutics-announces-trial-in-progress-poster-for-first-in-human-study-of-atx-559-at-2025-asco-annual-meeting-302461098.html
28 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/accent-therapeutics-presents-data-supporting-therapeutic-potential-of-first-in-class-dhx9-inhibitor-atx-559-and-novel-kif18a-inhibitor-atx-295-at-the-aacr-annual-meeting-2025-302438756.html
15 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/accent-therapeutics-announces-first-patient-dosed-in-phase-12-trial-of-novel-kif18a-inhibitor-atx-295-and-receives-fda-fast-track-designation-for-lead-assets-atx-295-and-dhx9-inhibitor-atx-559-302427964.html
25 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/accent-therapeutics-to-present-data-on-lead-programs-atx-559-and-atx-295-at-the-2025-american-association-for-cancer-research-annual-meeting-302409611.html
24 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/accent-therapeutics-announces-fda-clearance-of-ind-application-for-atx-559-a-first-in-class-oral-dhx9-inhibitor-302285845.html
08 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/accent-therapeutics-presents-data-supporting-two-lead-programs-at-aacr-2024-annual-meeting-302110786.html
ABOUT THIS PAGE